fbpx
July 14, 2022

FDA OKs Crizotinib for Myofibroblastic Tumors FDA OKs Crizotinib for Myofibroblastic Tumors

The US Food and Drug Administration (FDA) has approved crizotinib (Xalkori) for the treatment of unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors […]
July 11, 2022

FDA Approves Combination Pegloticase and Methotrexate for Gout FDA Approves Combination Pegloticase and Methotrexate for Gout

The US Food and Drug Administration (FDA) has approved concomitant use of the biologic pegloticase (Krystexxa) and methotrexate to lower serum uric acid levels (sUA) in […]
June 30, 2022

Irritable Bowel Syndrome Therapy Removed From Market (Again) Irritable Bowel Syndrome Therapy Removed From Market (Again)

Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from the US market effective June 30, according to the […]
June 30, 2022

FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug

The US Food and Drug Administration issued a warning today that the cancer drug duvelisib (Copiktra, Verastem Inc), a PI3 kinase inhibitor, may increase the risk […]
June 28, 2022

White House Expands Access to Monkeypox Vaccines White House Expands Access to Monkeypox Vaccines

The White House is scaling up their response to the monkeypox outbreak, expanding access to vaccines to more at-risk individuals, officials said in a press call. […]
June 28, 2022

FDA Class 1 Recall: Batteries for CARESCAPE 2860 Ventilator FDA Class 1 Recall: Batteries for CARESCAPE 2860 Ventilator

The US Food and Drug Administration (FDA) has issued a Class I Recall for the CARESCAPE R860/Engstrom Carestation/Engstrom PRO Ventilator batteries. A total of 1533 complaints […]
June 28, 2022

FDA Approves Qsymia for Treating Teens With Obesity FDA Approves Qsymia for Treating Teens With Obesity

The US Food and Drug Administration (FDA) has approved a supplemental indication for the combination phentermine and topiramate extended-release capsules (Qsymia, Vivus LLC) in patients aged […]
June 28, 2022

Upadacitinib Recommended for Nonradiographic AxSpA in Europe Upadacitinib Recommended for Nonradiographic AxSpA in Europe

Upadacitinib may soon be used for the treatment of nonradiographic axial spondyloarthritis (nr-axSpA) after the European Medicines Agency’s Committee for Medicinal Products for Human Use gave it […]
June 27, 2022

FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma

Lisocabtagene maraleucel, also known as liso-cel (Breyanzi), has been approved by the Food and Drug Administration for the second-line treatment of adult patients with relapsed or […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0